Joleen M (Turja) Hubbard MD

Summary

• Dr. Joleen Hubbard is a gastrointestinal oncologist with clinical and research focus on colorectal and anal cancers. She attended medical school and residency at the University of Minnesota and completed hematology/oncology fellowship at Mayo Clinic Rochester. Dr. Hubbard joined the staff as a Mayo Clinic Scholar in 2010. During her time at Mayo Clinic, she was the principal investigator of multiple phase I, II, and III clinical trials in gastrointestinal cancers. She was also the Chair of the Gastrointestinal Oncology Group and subsequently of the Medical Oncology Practice at Mayo Clinic.
  
  Dr. Hubbard served as a member of the NCCN colorectal/anal/small bowel guidelines panel and a member of the GI Oncology committees for the Alliance cooperative group. She currently serves on the board of directors for the ACCRU clinical trials network and is a member of the Society for Immunotherapy of Cancer Gastrointestinal Cancers Immunotherapy Guideline Expert Panel. She has over 90 peer reviewed publications and presented her research at multiple national and international oncology meetings.
  
  In August 2023, Dr. Hubbard started a new position as the Deputy Director for Clinical Research and Academic Affairs at the Allina Health Cancer Institute at Abbott Northwestern Hospital in Minneapolis, MN. Her goal is to develop a premier clinical research program that brings opportunities for patients to receive innovative cancer treatments in the Twin Cities and surrounding communities